T cell memory and protective immunity by vaccination: is more better?
- PMID: 16997631
- DOI: 10.1016/j.it.2006.09.004
T cell memory and protective immunity by vaccination: is more better?
Abstract
Protection against intracellular pathogens or tumor antigens requires T-cell mediated responses. Recently, it has become apparent that protection against disease correlates with T cells of the central memory type in many instances. Here, we analyze current data to distill a set of rules for the induction and maintenance of central memory T-cell responses. Recent studies show that T-cell help and the lack of overt inflammation at the time of priming are prerequisite for the induction, maintenance and expansion of memory T cells. Central to our hypothesis is that, in addition to these factors, successful vaccination in the immunologically inexperienced individual should be based on low antigen dose, to decelerate replicative senescence in responding cells and favor lineage differentiation of central memory T cells. In the immunologically experienced individual, it will be necessary, in addition, to abate the antigen load in plasma before vaccination. These guiding principles might help to raise improved protective T-cell responses by vaccination in humans.
Similar articles
-
[Novel vaccines against M. tuberculosis].Kekkaku. 2006 Dec;81(12):745-51. Kekkaku. 2006. PMID: 17240920 Review. Japanese.
-
Primer: making sense of T-cell memory.Nat Clin Pract Rheumatol. 2008 Jan;4(1):43-9. doi: 10.1038/ncprheum0671. Nat Clin Pract Rheumatol. 2008. PMID: 18172448 Review.
-
On immunity against infections and vaccines: credo 2004.Scand J Immunol. 2004 Jul-Aug;60(1-2):9-13. doi: 10.1111/j.0300-9475.2004.01460.x. Scand J Immunol. 2004. PMID: 15238068 Review.
-
Significance of senescence for virus-specific memory T cell responses: rapid ageing during chronic stimulation of the immune system.Immunol Lett. 2005 Feb 15;97(1):19-29. doi: 10.1016/j.imlet.2004.10.003. Immunol Lett. 2005. PMID: 15626472 Review.
-
Assessing ageing of individual T lymphocytes: mission impossible?Mech Ageing Dev. 2008 Jan-Feb;129(1-2):67-78. doi: 10.1016/j.mad.2007.10.005. Epub 2007 Oct 30. Mech Ageing Dev. 2008. PMID: 18048082 Review.
Cited by
-
Therapeutic cancer vaccines: advancements, challenges, and prospects.Signal Transduct Target Ther. 2023 Dec 13;8(1):450. doi: 10.1038/s41392-023-01674-3. Signal Transduct Target Ther. 2023. PMID: 38086815 Free PMC article. Review.
-
Immunology to Immunotherapeutics of SARS-CoV-2: Identification of Immunogenic Epitopes for Vaccine Development.Curr Microbiol. 2022 Sep 5;79(10):306. doi: 10.1007/s00284-022-03003-3. Curr Microbiol. 2022. PMID: 36064873 Free PMC article. Review.
-
Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming.Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1650-5. doi: 10.1073/pnas.0707140104. Epub 2008 Jan 23. Proc Natl Acad Sci U S A. 2008. PMID: 18216244 Free PMC article. Clinical Trial.
-
Selected microRNAs define cell fate determination of murine central memory CD8 T cells.PLoS One. 2010 Jun 22;5(6):e11243. doi: 10.1371/journal.pone.0011243. PLoS One. 2010. PMID: 20582165 Free PMC article.
-
Activation phenotype, rather than central- or effector-memory phenotype, predicts the recall efficacy of memory CD8+ T cells.J Exp Med. 2007 Jul 9;204(7):1625-36. doi: 10.1084/jem.20070322. Epub 2007 Jul 2. J Exp Med. 2007. PMID: 17606632 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical